Accuray Buys TomoTherapy To Create 'Premier' Radiation Oncology Company
This article was originally published in The Gray Sheet
Executive Summary
Radiosurgery device maker Accuray is acquiring radiation therapy developer TomoTherapy for $277 million in cash and stock to form “the premier radiation oncology company,” according to the firms.